In addition to the role in metabolic diseases, as an osteosarcoma-promoting miRNA, miR-18a-5p can also target the suppressor of cytokine signalling 5 in OS cells, which induced tumorigenesis [19]. The gene discussed is SOCS5; the disease is Other metabolic disease.